Strategy
MSTR
Coinbase
COIN
Tesla
TSLA
4
Vale SA
VALE
5
Salesforce
CRM
US Stock MarketDetailed Quotes
SHPH Shuttle Pharmaceuticals
- 0.420
- -0.021-4.85%
Close Mar 11 16:00 ET
- 0.420
- 0.0000.00%
Post 16:20 ET
1.71MMarket Cap-0.13P/E (TTM)
0.440High0.381Low87.66KVolume0.426Open0.442Pre Close36.38KTurnover3.00%Turnover RatioLossP/E (Static)4.08MShares4.71052wk High2.41P/B1.23MFloat Cap0.38152wk Low--Dividend TTM2.93MShs Float1010.080Historical High--Div YieldTTM13.30%Amplitude0.381Historical Low0.415Avg Price1Lot Size
About Shuttle Pharmaceuticals Company
Shuttle Pharmaceuticals Holdings, Inc. is a clinical stage pharmaceutical company, which engages in the development of novel therapies for cancer. It also offers cancer treatments with surgery, radiation therapy, chemotherapy, and immunotherapy. The company was founded by Anatoly Dritschilo, Mira Jung, and Milton Brown on December 18, 2012 and is headquartered in Gaithersburg, MD.
Company Profile
SymbolSHPH
Company NameShuttle Pharmaceuticals
Listing DateAug 31, 2022
Issue Price8.12
Founded2012
CEODr. Anatoly Dritschilo, M.D.
MarketNASDAQ
Employees9
Fiscal Year Ends12-31
Address401 Professional Drive,Suite 260
CityGaithersburg
ProvinceMaryland
CountryUnited States of America
Zip Code20879
Phone1-240-403-4212
Websitehttp://www.shuttlepharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Anatoly Dritschilo, M.D.
- Chairman of the Board and Chief Executive Officer
- 399.18K
- Timothy J. Lorber
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Tyvin A. Rich, M.D.
- Chief Clinical Officer
- 263.23K
- Peter Dritschilo
- President and Chief Operating Officer
- 314.01K
- Dr. Mira Jung, M.A.,PhD
- Chief Scientific Officer
- --
- Michael P. Vander Hoek
- Vice President, Operations and Regulatory and Principal Accounting Officer
- 302.53K
- Joseph Tung
- Director
- --
- George Scorsis
- Director
- --
- Oleh Nabyt
- Director
- --
- Steven Richards, C.P.A.
- Independent Director
- --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!